Annual CFF
$362.72 M
+$265.55 M+273.30%
December 31, 2023
Summary
- As of February 7, 2025, IDYA annual cash flow from financing activities is $362.72 million, with the most recent change of +$265.55 million (+273.30%) on December 31, 2023.
- During the last 3 years, IDYA annual CFF has risen by +$233.97 million (+181.72%).
- IDYA annual CFF is now at all-time high.
Performance
IDYA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$286.50 M
+$247.32 M+631.19%
September 30, 2024
Summary
- As of February 7, 2025, IDYA quarterly cash flow from financing activities is $286.50 million, with the most recent change of +$247.32 million (+631.19%) on September 30, 2024.
- Over the past year, IDYA quarterly CFF has increased by +$145.61 million (+103.35%).
- IDYA quarterly CFF is now -17.93% below its all-time high of $349.11 million, reached on March 31, 2024.
Performance
IDYA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$815.69 M
+$258.67 M+46.44%
September 30, 2024
Summary
- As of February 7, 2025, IDYA TTM cash flow from financing activities is $815.69 million, with the most recent change of +$258.67 million (+46.44%) on September 30, 2024.
- Over the past year, IDYA TTM CFF has increased by +$452.98 million (+124.88%).
- IDYA TTM CFF is now at all-time high.
Performance
IDYA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IDYA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +273.3% | +103.3% | +124.9% |
| 3 y3 years | +181.7% | +103.3% | +124.9% |
| 5 y5 years | +244.2% | +10000.0% | +1484.8% |
IDYA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +273.3% | -17.9% | >+9999.0% | at high | +820.6% |
| 5 y | 5-year | at high | +616.7% | -17.9% | >+9999.0% | at high | +1511.7% |
| alltime | all time | at high | +1973.8% | -17.9% | >+9999.0% | at high | >+9999.0% |
IDEAYA Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $286.50 M(+631.2%) | $815.69 M(+46.4%) |
| Jun 2024 | - | $39.18 M(-88.8%) | $557.02 M(-21.4%) |
| Mar 2024 | - | $349.11 M(+147.8%) | $708.90 M(+95.4%) |
| Dec 2023 | $362.72 M(+273.3%) | $140.89 M(+406.2%) | $362.72 M(+63.3%) |
| Sep 2023 | - | $27.83 M(-85.4%) | $222.15 M(-23.4%) |
| Jun 2023 | - | $191.06 M(+6429.8%) | $290.01 M(+191.6%) |
| Mar 2023 | - | $2.93 M(+803.1%) | $99.44 M(+2.3%) |
| Dec 2022 | $97.17 M(-33.2%) | $324.00 K(-99.7%) | $97.17 M(-0.4%) |
| Sep 2022 | - | $95.70 M(>+9900.0%) | $97.53 M(+10.1%) |
| Jun 2022 | - | $491.00 K(-24.8%) | $88.61 M(-14.9%) |
| Mar 2022 | - | $653.00 K(-5.1%) | $104.10 M(-28.4%) |
| Dec 2021 | $145.45 M | $688.00 K(-99.2%) | $145.45 M(-4.1%) |
| Sep 2021 | - | $86.78 M(+442.8%) | $151.72 M(+64.9%) |
| Jun 2021 | - | $15.99 M(-61.9%) | $92.01 M(-46.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $42.00 M(+504.5%) | $170.72 M(+32.6%) |
| Dec 2020 | $128.75 M(+154.4%) | $6.95 M(-74.3%) | $128.75 M(+5.7%) |
| Sep 2020 | - | $27.07 M(-71.4%) | $121.84 M(+28.9%) |
| Jun 2020 | - | $94.70 M(>+9900.0%) | $94.50 M(+83.6%) |
| Mar 2020 | - | $34.00 K(-10.5%) | $51.47 M(+1.7%) |
| Dec 2019 | $50.61 M(-52.0%) | $38.00 K(-113.8%) | $50.61 M(+0.2%) |
| Sep 2019 | - | -$276.00 K(-100.5%) | $50.49 M(-0.6%) |
| Jun 2019 | - | $51.67 M(-6355.9%) | $50.81 M(-5953.9%) |
| Mar 2019 | - | -$826.00 K(+972.7%) | -$868.00 K(-100.8%) |
| Dec 2018 | $105.38 M(+502.5%) | -$77.00 K(-287.8%) | $105.38 M(-0.1%) |
| Sep 2018 | - | $41.00 K(-783.3%) | $105.45 M(+0.0%) |
| Jun 2018 | - | -$6000.00(-100.0%) | $105.41 M(-0.0%) |
| Mar 2018 | - | $105.42 M | $105.42 M |
| Dec 2017 | $17.49 M | - | - |
FAQ
- What is IDEAYA Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual CFF year-on-year change?
- What is IDEAYA Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly CFF year-on-year change?
- What is IDEAYA Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for IDEAYA Biosciences?
- What is IDEAYA Biosciences TTM CFF year-on-year change?
What is IDEAYA Biosciences annual cash flow from financing activities?
The current annual CFF of IDYA is $362.72 M
What is the all time high annual CFF for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual cash flow from financing activities is $362.72 M
What is IDEAYA Biosciences annual CFF year-on-year change?
Over the past year, IDYA annual cash flow from financing activities has changed by +$265.55 M (+273.30%)
What is IDEAYA Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of IDYA is $286.50 M
What is the all time high quarterly CFF for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly cash flow from financing activities is $349.11 M
What is IDEAYA Biosciences quarterly CFF year-on-year change?
Over the past year, IDYA quarterly cash flow from financing activities has changed by +$145.61 M (+103.35%)
What is IDEAYA Biosciences TTM cash flow from financing activities?
The current TTM CFF of IDYA is $815.69 M
What is the all time high TTM CFF for IDEAYA Biosciences?
IDEAYA Biosciences all-time high TTM cash flow from financing activities is $815.69 M
What is IDEAYA Biosciences TTM CFF year-on-year change?
Over the past year, IDYA TTM cash flow from financing activities has changed by +$452.98 M (+124.88%)